INOVIO Pharmaceuticals
NEWS ALERT

Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications

Press Releases

INOVIO Reports Third Quarter 2020 Financial Results

Posted on November 9, 2020

INOVIO to Report Third Quarter 2020 Financial Results on November 9, 2020

Posted on October 26, 2020

INOVIO Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial of COVID-19 Vaccine Candidate INO-4800

Posted on September 28, 2020

INOVIO Adds Thermo Fisher Scientific To Global Manufacturing Consortium

Posted on September 8, 2020

INOVIO to Present at Upcoming Investor Conferences in September

Posted on September 1, 2020

SUBSCRIBE FOR UPDATES FROM INOVIO
Register to receive email alerts for INOVIO press releases

© Copyright 2025 INOVIO Pharmaceuticals. All rights reserved.